Moneycontrol
HomeNewsIndiaCoronavirus impact: Near-term outlook for FMCG sector 'extremely uncertain', says HUL
Trending Topics

Coronavirus impact: Near-term outlook for FMCG sector 'extremely uncertain', says HUL

While describing the current situation as "much more uncertain than normal", the FMCG major added that it is confident about its ability to manage the immediate crisis.

June 06, 2020 / 13:15 IST
Story continues below Advertisement

The near-term outlook for the FMCG market is "extremely uncertain" as the COVID-19 outbreak had a "terrible impact" and the situation remains volatile with the trajectory of the coronavirus undetermined, according to HUL.

While describing the current situation as "much more uncertain than normal", the FMCG major added that it is confident about its ability to manage the immediate crisis.

Story continues below Advertisement

"The situation remains volatile with the trajectory of the virus undetermined, evolving hot spot geographies, the success of containment measures uncertain, the severity and duration of resulting economic crisis and the extent of structural damage unknown," HUL Chairman and Managing Director Sanjiv Mehta said in his address to shareholders in the company's annual report for 2019-20.

Coronavirus India News LIVE Updates

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show